Mr. Yazbeck is a former Pfizer scientist, Panasonic new product, market and business developer, and a strategic marketing expert who has been featured in Bloomberg, CNN, VICE News, Fast Company, Yahoo Finance, ABC, NBC, PBS, CNET, amongst others. He founded Yazbeck Investments in 2007 and focussed on asset backed investments until he started investing in the Legal Cannabis Industry in 2013.
Some of his Early Cannabis Investments include:
MyDx in 2013 – now a leader in cannabis health technology tracking the science of how cannabis makes people feel which which Mr. Yazbeck took public as its CEO on the US OTC Exchange in 2015.
Ebbu in 2014 – a leader in hemp research acquired in 2018 for $330 million by Canopy Growth Corporation.
Manifest 7 (formerly MJIC) in 2015 – Owns a portfolio of companies and is now a leading distribution company in California on a path to becoming public on the Canadian stock exchange.
More Recent Cannabis Investments include:
Flip Distro in 2019, a software driven METRC Compliant marketplace facilitating licensed wholesale cannabis distribution & logistics in California.
Ramona Cannabis Company in 2020, a San Diego county licensed and vertically integrated cannabis company operating a profitable retail dispensary and delivery service, a manufacturing and co-packing facility, a distribution hub, and is licensed for cannabis cultivation.
Since 2018, Yazbeck has also been working closely with local Lebanese scientists, business leaders, activists and government regulators to help draft and pass a law to legalize cannabis in Lebanon. On April 21, 2020, Lebanon passed legislation legalizing medical cannabis cultivation in the country.
Ongoing Investment and Support
Daniel continues to support the companies he invests in by leveraging nearly 15 years of network and experience with Fortune 500 and Yazbeck Investments, as well as nearly 10 years of operating experience in the legal cannabis industry.